• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.67% Nasdaq Up1.47%

    More On JUBILANT.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Jubilant Life Sciences Limited (JUBILANT.NS)

    -NSI
    171.05 Up 0.05(0.03%) 5:59AM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Mar 31, 2014Mar 31, 2013Mar 31, 2012
    Net Income (578,000) 1,090,000   1,527,000   146,000  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation -  2,309,000  2,538,000  2,207,000  
    Adjustments To Net Income -   -   -   -  
    Changes In Accounts Receivables -  507,000  (919,000)(977,000)
    Changes In Liabilities -   -   -   -  
    Changes In Inventories -  (1,750,000)(656,000)(2,824,000)
    Changes In Other Operating Activities -   -   -   -  
    Total Cash Flow From Operating Activities -   8,026,000   9,699,000   7,072,000  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures -  (2,908,000)(4,638,000)(6,146,000)
    Investments -   -   -   -  
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities -   (1,744,000) (4,997,000) (5,943,000)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock -   -   -   -  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities -  693,000  (620,000)231,000  
    Total Cash Flows From Financing Activities -   (4,447,000) (4,498,000) (8,888,000)
    Effect Of Exchange Rate Changes -  114,000  (38,000)(41,000)
    Change In Cash and Cash Equivalents -   1,938,000   166,000   (7,781,000)

    Currency in INR.